1. Antitumor activity of didemnin B in the human tumor stem cell assay

   • T. L. Jiang
   • R. H. Liu
   • S. E. Salmon

   Original Articles Pages: 1 - 4

2. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients

   • H. Sharma
   • N. Thatcher
   • B. W. Fox

   Original Articles Pages: 5 - 7

3. Properties of anticancer agents relevant to in vitro determinations of human tumor cell sensitivity

   • Edward J. Pavlik
   • Daniel E. Kenady
   • Robert C. Flanigan

   Original Articles Pages: 8 - 15

4. A phase II study of high-dose medroxyprogesterone acetate in advanced breast cancer

   • Geoffrey Falkson
   • Hèndré C. Falkson

   Original Articles Pages: 16 - 18

5. Medroxyprogesterone acetate (MAP) plasma levels after multiple high-dose administration in advanced cancer patients

   • Carlo Maurizio Camaggi
   • Elena Strocchi
   • Franco Pannuti

   Original Articles Pages: 19 - 22

6. Pharmacokinetics of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum IV (CHIP) in patients with advanced cancer

   • L. Pendyala
   • W. Greco
   • P. J. Creaven

   Original Articles Pages: 23 - 28

7. Plasma levels of 7-hydroxymethotrexate after high-dose methotrexate treatment

   • G. Milano
   • A. Thyss
   • C. M. Lalanne

   Original Articles Pages: 29 - 32

8. Lack of activity of cyclophosphamide in ovarian cancer patients refractory to cis-dichlorodiammine platinum

   • C. Sessa
   • M. D'Incalci
   • C. Mangioni

   Original Articles Pages: 33 - 34

9. cis-platinum and etoposide combination chemotherapy of advanced non-oat cell bronchogenic carcinoma

   • Andrea Veronesi
   • Vittorina Zagonel
   • Eligio Grigoletto

   Original Articles Pages: 35 - 37

10. Influence of scheduling on therapeutic and toxic effect of AMSA in Lewis lung carcinoma

    • Claudia Greco
    • Gabriella Zupi
    • Gianna Badaracco

    Original Articles Pages: 38 - 42

11. A phase I–II study of combination therapy with thymidine and cytosine arabinoside

    • R. Fram
    • P. Major
    • D. Kufe

    Original Articles Pages: 43 - 47

12. Phase II study of chlorozotocin in islet cell carcinoma

    • Ronald M. Bukowski
    • Joseph D. McCracken
    • Carol J. Fabian

    Original Articles Pages: 48 - 50

13. Distribution, metabolism, and irreversible binding of hexamethylmelamine in mice bearing ovarian carcinoma

    • Enrico Garattini
    • Tina Colombo
    • Claudio Pantarotto

    Original Articles Pages: 51 - 55

14. Experience with human lymphoblastoid interferon in acute myelogenous leukaemia (AML)

    • Ama Z. S. Rohatiner
    • Frances R. Balkwill
    • T. Andrew Lister

    Original Articles Pages: 56 - 58

15. Phase-I study of α-1,3,5-Triglycidyl-s-triazinetrione (NSC 296934)

    • Per Dombernowsky
    • Birthe Lund
    • Heine Høi Hansen

    Original Articles Pages: 59 - 61

16. An investigation of the mouse as a model for vincristine toxicity

    • Steadman D. Harrison Jr

    Original Articles Pages: 62 - 65

17. Oral levonantradol in the control of cancer chemotherapy-induced emesis

    • John Welsh
    • Fraser Stuart
    • Kenneth Calman

    Short Communication Pages: 66 - 67

18. Meeting announcements

    Announcement Pages: 68 - 68